The AHSN Network has supported many innovators to help advance our health and care system. Find out more about successful innovations supported by the NHS.
Find your nearest AHSN
REST EASY Training - Mental health support for schools, families & businesses.
REST EASY Training offer a simple, affordable, effective wellbeing methodology for schools, staff & families. The method forms part of a whole school approach & intervention strategy that teaches children, parents & staff how to recognise & manage emotions using our simple REST EASY acronym. We are evaluated against the NICE guidelines for social, emotional & mental wellbeing needs in schools & meet all DfE pinciples & SEL requirements.
Oxford AHSN support helps digital innovators develop and roll out automated surgery follow-up call
Ufonia is an innovative digital health company based in Oxford comprising a team of clinical, software and artificial intelligence experts. It was founded by a neurosurgeon with experience leading NHS digital programmes and is applying AI technologies to solve some of the biggest challenges in healthcare.
MyWay Digital Health (MWDH) is a University of Dundee spin out. MyWay Diabetes (MWD) their flagship product, developed with NHS Scotland, is the only self-management platform globally to be scaled across an entire country ( >500,000 web users, >65,000 data registrants). MyDiabetes Clinical is a complementary clinician platform supporting individual/ population evidence-based management/ decision support, risk profiling and analytics. MWDH is NHS Innovation Accelerator Alumni, has won Digital Leaders impact award (2021) European ehealth adopters award (2017), DiabetesUK QiC self-management award (2015).
Biologics for treating severe asthma: Reslizumab, Benralizumab, Mepolizumab and Omalizumab
Less than 50% of severe asthma patients have eosinophil-driven disease (Wenzel2005) and Biologics are designed to control the number of eosinophil cells (Asthma UK). Only 10.8% of eligible severe asthma patients have access to biologic medicines today in the UK. Increasing the use of biologics appropriately would reduce use of Oral corticosteroids (OCS), associated with negative side effects, and exacerbations, causing 75,000 annual UK hospital admissions, each costing £1500.
Measuring fractional exhaled nitric oxide (FeNO) concentration in asthma: products NIOX VERO and NObreath
FeNO (Fractional exhaled Nitric Oxide) testing alongside the recommended NICE diagnostic tests, will help enable more accurate diagnosis of asthma. Over 120,000 patients a year, 30% of the asthma population, are wrongly diagnosed and given inappropriate medication. This project will look to reduce the use of steroids and improve diagnosis, enabling correct adjustments or the right medication to be prescribed. FeNO is indicative of the severity of airway inflammation.
Lipid Management: High Intensity Statins, Ezetimibe and PCSK9 inhibitors
Lipid Management: High-Intensity Statins, Ezetimibe and PCSK9 inhibitors is one of the NHS England Accelerated Access Collaborative’s Rapid Uptake Products (RUP). This innovation focuses on reducing cholesterol concentration in blood by treating patients with the right medicine or lifestyle advice along the evidence-based pathway. The pathway includes three medicines: high intensity statins (HIST), ezetimibe, and PCSK9 inhibitors, with further innovative therapies for secondary prescribing expected to follow.
Concentric digital consent
Concentric is a digital consent (aka econsent) application which transforms the traditional paper consent form process and is now in use across a number of NHS Trusts and Health Boards across the UK, including Imperial College Healthcare NHS Trust and Chelsea and Westminster Hospitals NHS Foundation Trust.Consent for treatment is a key element of care, in terms of the quality of clinical decision-making, experiences of patient-centred care, and organisational medico-legal risk.
Advance and Urgent Care Plans – London Accelerator
In July 2020, The Health Innovation Network (HIN) were commissioned to deliver a programme to increase use and quality of shared electronic advance/urgent care plans using Co-ordinate my Care (CMC). The programme concentrated on clinical engagement.
Automated Scheduling for Elective Care Appointments
COVID-19 has generated a significant backlog of elective patients that need appointments generated as quickly as possible. Trusts are keen to avoid hiring more staff to solve the problem and are looking to digital workers instead. Bots can assist with the recovery of elective care in a predictable and consistent way. For example, Automation Anywhere's Robotic Interface (AARI) can be used to extract patient details from referral systems, before cross-checking details against SPINE. Once validated, bookings can be made within the PAS terminal. All bookings and referrals are triaged in e-RS (e-Referral Service) with the outcome.
Maximising Digital Opportunities in Perinatal Mental Health and Wellbeing
Did you know that 20% of women experience mental health problems during the perinatal period? Partners can also experience mental health problems during this time. Utilising digital solutions can support women, partners and families when experiencing perinatal mental health challenges.
YOURmeds is a digital monitored dosage system, supporting users to take their medicines as intended and so maintain their safety and independence, whilst ensuring they get the best clinical outcomes from their medicines.
Digital First Waiting List Validation
Healthcare Communications waiting list solution is currently supporting 23 trusts to rapidly communicate with patients about recommencing their treatment across elective care, outpatients and diagnostics. Taking a digital first, yet fully inclusive engagement approach, the platform will automatically switch to multi-channel options to reach patients who don’t or can’t access the digital communication. The solution empowers instant engagement, offering patients the option to self-select responses from their mobile, whilst avoiding long phone queue times, and with the analytics to immediately flag urgent patients for clinical review.